BioCentury
ARTICLE | Clinical News

FluINsure intranasal vaccine: Phase II

June 30, 2003 7:00 AM UTC

Pooled immunogenicity data of 252 healthy adults from various Phase II trials showed that patients who received either 1 or 2 doses of FluINsure showed significant increases in nasal secretory IgA lev...